SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Gianella RA, Broitman SA & Zamcheck N. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro. Gut 1972; 13: 2516.
  • 2
    Hunt RH. The protective role of gastric acid. Scand J Gastroenterol 1988; 23(Suppl. 146): 349.
  • 3
    Wilder-Smith CH, Spirig C, Krech T & Merki HS. Bactericidal factors in gastric juice. Eur J Gastroenterol Hepatol 1992; 4: 88591.
  • 4
    Stockbrügger RW, Cotton PB & Menon GG, et al. Pernicious anaemia, intragastric bacterial overgrowth, and possible consequences. Scand J Gastroenterol 1984; 19: 35564.
  • 5
    Stockbrügger RW. Bacterial overgrowth as a consequence of reduced gastric acidity. Scand J Gastroenterol 1985; 111(Suppl.): 716.
  • 6
    El-Omar EM, Oien K & El-Nujumi A, et al. Helicobacter pylori infection and chronic gastric acid hyposecretion. Gastroenterology 1997; 113: 1524.
  • 7
    Enander LK, Nilsson F, Ryden AC & Schwan A. The aerobic and anaerobic microflora of the gastric remnant more than 15 years after Billroth II resection. Scand J Gastroenterol 1982; 17: 71520.
  • 8
    Festen HPM. Profound gastric acid inhibition. Advantages and potential hazards. Scand J Gastroenterol 1989; 24(Suppl. 171): 99105.
  • 9
    Modlin IM, Goldenring JR, Lawton GP & Hunt R . Aspects of the theoretical basis and clinical relevance of low acid states. Am J Gastroenterol 1994; 89: 30818.
  • 10
    Wingate DL. Acid reduction and recurrent enteritis. Lancet 1990; i: 222222.
  • 11
    Saltzman JR, Kowsley KV & Pedrosa MC, et al. Bacterial overgrowth without clinical malabsorption in elderly hypochlorhydric patients. Gastroenterology 1994; 106: 61523.
  • 12
    Stockbrügger RW, Cotton PB, Eugenides N, Bartholomew BA, Hill MJ & Walters CL. Intragastric nitrates, nitrosamines, and bacterial overgrowth during cimetidine treatment. Gut 1982; 23: 104854.
  • 13
    Sharma BK, Santana IA & Wood EC, et al. Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J 1984; 289: 7179.
  • 14
    Verdu E, Viani F & Armstrong D, et al. Effects of omeprazole on intragastric bacterial counts, nitrates, nitrites, and N-nitroso compounds. Gut 1994; 35: 44560.
  • 15
    Houben GMP, Hooi J, Brummer RJ, Stobberingh EE & Stockbrügger RW. Intragastric bacterial growth, nitrates and N-nitroso compounds after 300 mg ranitidine b.d., 20 mg omeprazole, 40 mg omeprazole and placebo. Eur J Cancer Prevention 1996; 5(Suppl. 1): 5961.
  • 16
    Brummer RJ & Stockbrügger RW. Effect of nizatidine 300 mg at night and omeprazole 20 mg in the morning on 24-hour intragastric pH and bacterial overgrowth in patients with acute duodenal ulcer. Dig Dis Sci 1996; 41: 204854.
  • 17
    Logan RPH, Walker MM, Misiewicz JJ, Gummett PA, Karim QN & Baron JH. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut 1995; 36: 126.
  • 18
    Kuipers EJ, Lundell L & Klinkenberg-Knoll E, et al. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication. N Engl J Med 1996; 334: 101822.
  • 19
    Lundell L, Miettinen P & Myrvold HE, et al. Lack of effect of acid suppression therapy on gastric atrophy. Gastroenterology 1999; 117: 31926.
  • 20
    Jönsson KA, Ström M, Bodemar G & Norrby K. Histologic changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988; 23: 43341.
  • 21
    Meining A, Bosseckert H, Caspary WF, Nauert C & Stolte M. H2-receptor-antagonists as well as antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients. Aliment Pharmacol Ther 1997; 11: 72934.
  • 22
    Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W & Stockbrügger RW. Double gastric infection with Helicobacter pylori and non-Helicobacter pylori bacteria enhances the expression of circulating pro-inflammatory cytokines and parallels the development of atrophic corpus gastritis. Gut 2000; 47(Suppl. III): A110A110.
  • 23
    Sanduleanu S, Jonkers D, De Bruine A, Hameeteman W & Stockbrügger RW. Does double infection of the stomach with Helicobacter pylori and non-Helicobacter pylori bacterial flora accelerate the development of atrophic gastritis in patients treated with gastric acid inhibition. Gut 2000; 47(Suppl. III): A31A31.
  • 24
    Dolby JM, Webster ADB, Borriello SP, Barclay FE, Bartholomew BA & Hill MJ. Bacterial colonization and nitrate concentration in the achlorhydric stomachs of patients with primary hypogammaglobulinaemia or classical pernicious anaemia. Scand J Gastroenterol 1984; 19: 10510.
  • 25
    Jonkers D, Gisbertz I & De Bruine A, et al. Helicobacter pylori and non-Helicobacter pylori bacterial flora in gastric mucosal and tumour specimens of patients with primary gastric lymphoma. Eur J Clin Invest 1997; 27: 88592.
  • 26
    Jonkers D, Houben P & Hameeteman W, et al. Differential features of gastric cancer patients, either Helicobacter pylori positive or Helicobacter pylori negative. Ital J Gastroenterol Hepatol 1999; 31: 83641.
  • 27
    Bonten M, Gaillard C, Stockbrügger RW, Van-Tiel F, Van-der-Geest S & Stobberingh E. Assessment of gastric acidity in intensive care patients: intermittent pH registration cannot replace continuous pH monitoring. Intensive Care Med 1996; 22: 2205.
  • 28
    Balows A, Hausler WJ, Hermann KL, Isenberg HD & Shadomy HJ. Manual of Clinical Microbiology, 5th edn. Washington DC: American Society For Microbiology, 1991.
  • 29
    Dixon MF, Genta RM, Yardley JA & Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol 1996; 20: 116181.
  • 30
    Verdu EF, Armstrong D & Fraser R, et al. Effect of Helicobacter pylori status on intragastric pH during treatment with omeprazole. Gut 1995; 36: 53943.
  • 31
    Labenz J, Tillenburg B & Peitz U, et al. Helicobacter pylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110: 72532.
  • 32
    Gillen D, Williams C, Hossack M, Gilmore D & McColl KEL. Helicobacter pylori infection predisposes to gastric colonisation by other bacteria during omeprazole treatment. Gut 1998; 42: A3A3(Abstract).
  • 33
    Karmeli Y, Stalnikowitz R, Eliakim R & Rahav G. Conventional dose of omeprazole alters gastric flora. Dig Dis Sci 1995; 40: 20703.
  • 34
    Hill MJ. Bacterial N-nitrosation and gastric carcinogenesis in humans. Ital J Gastroenterol 1991; 23: 1723.
  • 35
    Houben GM & Stockbrügger RW. Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol 1995; 212: 138.